| Valiant Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543998 |
NSE Symbol : VALIANTLAB |
P/E(TTM) : 57.20 |
|
ISIN Demat : INE0JWS01017 |
Div & Yield% : 0.00 |
EPS(TTM) : 1.26 |
|
Book Value(₹) : 58.44 |
Market Cap(₹Cr) : 391.43 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 45.99 | 51.01 | 57.77 | 35.23 | 21.48 | 18.88 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 45.99 | 51.01 | 57.77 | 35.23 | 21.48 | 18.88 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.85 | 0.67 | 0.65 | 0.67 | 1.93 | 2.17 |
| Total Income | 46.83 | 51.68 | 58.42 | 35.89 | 23.41 | 21.06 |
| Total Expenditure | 45.93 | 48.65 | 53.94 | 34.60 | 28.22 | 21.27 |
| PBIDT | 0.91 | 3.03 | 4.48 | 1.29 | -4.81 | -0.21 |
| Interest | 0.14 | 0.07 | 0.05 | 0.06 | 0.01 | 0.05 |
| PBDT | 0.77 | 2.96 | 4.43 | 1.23 | -4.81 | -0.27 |
| Depreciation | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.50 |
| Tax | 0.03 | 0.58 | 0.06 | 0.00 | -0.09 | 0.09 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.06 | 0.05 | 0.63 | -0.88 | 0.75 | 0.15 |
| Reported Profit After Tax | 0.17 | 1.82 | 3.24 | 1.60 | -5.98 | -1.01 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.17 | 1.82 | 3.24 | 1.60 | -5.98 | -1.01 |
| EPS (Unit Curr.) | 0.03 | 0.42 | 0.74 | 0.37 | -1.39 | -0.23 |
| EPS (Adj) (Unit Curr.) | 0.03 | 0.39 | 0.69 | 0.34 | -1.29 | -0.21 |
| Calculated EPS (Unit Curr.) | 0.04 | 0.42 | 0.75 | 0.37 | -1.38 | -0.23 |
| Calculated EPS (Adj) (Unit Curr.) | 0.04 | 0.39 | 0.70 | 0.34 | -1.28 | -0.21 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.15 | 1.67 | 2.98 | 1.47 | -5.51 | -0.93 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.15 | 1.55 | 2.77 | 1.36 | -5.11 | -0.86 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 43.45 | 43.45 | 43.45 | 43.45 | 43.45 | 43.45 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 1.98 | 5.94 | 7.75 | 3.66 | -22.39 | -1.11 |
| PBDTM(%) | 1.67 | 5.80 | 7.67 | 3.49 | -22.39 | -1.43 |
| PATM(%) | 0.37 | 3.57 | 5.61 | 4.54 | -27.84 | -5.35 |